Tofte Alena, Aghajani Faezeh, Jawwad Mohammad, Flood Anna, D'Antonio Francesco, Khalil Asma, Mustafa Hiba
Department of Obstetrics and Gynecology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire; BCNatal Fetal Medicine Research Center, University of Barcelona, Barcelona, Spain; B.P. Koirala Institute of Health Sciences, Dharan, Nepal; Indiana University School of Medicine, the Division of Maternal-Fetal Medicine, Indiana University School of Medicine, and the Fetal Center at Riley Children's and Indiana University Health, Indianapolis, Indiana; the Department of Obstetrics and Gynecology, Center for Fetal Care and High-Risk Pregnancy, University Hospital of Chieti, Chieti, Italy; and the Fetal Medicine Unit, St George's Hospital, and the Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom.
O G Open. 2024 Aug 8;1(3):23. doi: 10.1097/og9.0000000000000023. eCollection 2024 Sep.
To evaluate prenatal fetal imaging findings associated with survival to hospital discharge, persistent pulmonary hypertension (PH), and need for extracorporeal membrane oxygenation (ECMO) in fetuses with isolated congenital diaphragmatic hernia (CDH) that are undergoing prenatal expectant management.
A systematic search was conducted in MEDLINE through PubMed, EMBASE, Web of Science, and The Cochrane Central, and ClinicalTrials.gov from 2000 up to July 2023.
Studies that reported on prenatal imaging in fetuses with isolated CDH that were undergoing expectant management were included. Primary outcomes were survival to hospital discharge, persistent PH within 28 days of age, and need for ECMO. The quality of studies was assessed using the Newcastle-Ottawa Scale. Meta-analysis was performed when at least two studies reported on the same prenatal imaging evaluation. Subgroup analyses were performed according to the side (left or right) of CDH.
A total of 161 full-text articles were assessed for eligibility, with 48 studies meeting the inclusion criteria: 45 (N=3,977) assessed survival, eight (N=994) assessed persistent PH, and 12 (N=2,085) assessed need for ECMO. The pooled proportion was 2,833 of 3,977 (71.2%, 95% CI, 69.8-72.6%) for survival, 565 of 2,085 (27.1%, 95% CI, 25.2-29.1%) for need for ECMO, and 531 of 994 (53.4%, 95% CI, 50.3-56.6%) for need for persistent PH. Prenatal imaging findings that were significantly associated with survival included: total fetal lung volume (mean difference [MD] 13.42, 95% CI, 11.22-15.62), observed-to-expected (O-E) total fetal lung volume less than 30% (odds ratio [OR] 0.09, 95% CI, 0.05-0.17), O-E total fetal lung volume (MD 14.73, 95% CI, 11.62-17.84, 46%), liver/intrathoracic ratio (MD -9.59, 95% CI, -15.73 to -3.46), O-E lung/head ratio (MD 14.03, 95% CI, 12.69-15.36), O-E lung/head ratio less than 25% (OR 0.07, 95% CI, 0.04-0.13), mediastinal shift angle (MD -6.17, 95% CI, -7.70 to -4.64), stomach position in mid-chest (OR 0.14, 95% CI, 0.06-0.36), and intrathoracic liver (OR 0.23, 95% CI, 0.15-0.35). In subgroup analyses, findings for left-sided CDH remained significant in all the aforementioned findings. The only prenatal imaging finding that was significantly associated with persistent PH was intrathoracic liver (OR 1.96, 95% CI, 1.14-3.37), but this association was no longer significant in subgroup analyses. Prenatal imaging findings that were significantly associated with need for ECMO included: O-E total fetal lung volume (MD -10.08, 95% CI, -13.54 to -6.62), O-E lung/head ratio (MD -9.88, 95% CI, 14.44 to -5.33, 30%), subgroup analysis to the left-sided CDH remained significant, percentage of predicted lung volume (MD -9.81, 95% CI, -13.56 to -6.06, 34%), and intrathoracic liver (OR 2.70, 95% CI, 1.60-4.57, 0%), but this association was no longer significant in left-sided CDH subgroup analysis.
Several prenatal imaging findings, including lung measurements, intrathoracic liver, and stomach position, were predictive of neonatal survival. Lung measurement was predictive of need for ECMO, and intrathoracic liver was significantly associated with persistent PH and need for ECMO.
评估在接受产前期待治疗的孤立性先天性膈疝(CDH)胎儿中,与存活至出院、持续性肺动脉高压(PH)以及体外膜肺氧合(ECMO)需求相关的产前胎儿影像学表现。
2000年至2023年7月,通过PubMed、EMBASE、Web of Science、Cochrane Central以及ClinicalTrials.gov对MEDLINE进行了系统检索。
纳入报告接受期待治疗的孤立性CDH胎儿产前影像学的研究。主要结局为存活至出院、28日龄内持续性PH以及ECMO需求。使用纽卡斯尔-渥太华量表评估研究质量。当至少两项研究报告了相同的产前影像学评估时,进行荟萃分析。根据CDH的侧别(左侧或右侧)进行亚组分析。
共评估了161篇全文文章的 eligibility,48项研究符合纳入标准:45项(N = 3977)评估了存活情况,8项(N = 994)评估了持续性PH,12项(N = 2085)评估了ECMO需求。存活的合并比例为3977例中的2833例(71.2%,95%CI,69.8 - 72.6%),ECMO需求为2085例中的565例(27.1%,95%CI,25.2 - 29.1%),持续性PH需求为994例中的531例(53.4%,95%CI,50.3 - 56.6%)。与存活显著相关的产前影像学表现包括:胎儿肺总体积(平均差[MD]13.42,95%CI,11.22 - 15.62),观察到的与预期的(O - E)胎儿肺总体积小于30%(比值比[OR]0.09,95%CI,0.05 - 0.17),O - E胎儿肺总体积(MD 14.73,95%CI,11.62 - 17.84,46%),肝脏/胸腔内比值(MD - 9.59,95%CI,- 15.73至- 3.46),O - E肺/头比值(MD 14.03,95%CI,12.69 - 15.36),O - E肺/头比值小于25%(OR 0.07,95%CI,0.04 - 0.13),纵隔移位角度(MD - 6.17,95%CI,- 7.70至- 4.64),胃位于胸腔中部(OR 0.14,95%CI,0.06 - 0.36),以及胸腔内肝脏(OR 0.23,95%CI,0.15 - 0.35)。在亚组分析中,左侧CDH的上述所有表现仍然显著。与持续性PH显著相关的唯一产前影像学表现是胸腔内肝脏(OR 1.96,95%CI,1.14 - 3.37),但在亚组分析中这种关联不再显著。与ECMO需求显著相关的产前影像学表现包括:O - E胎儿肺总体积(MD - 10.08,95%CI,- 13.54至- 6.62),O - E肺/头比值(MD - 9.88,95%CI,14.44至- 5.33,30%),左侧CDH亚组分析仍然显著,预测肺体积百分比(MD - 9.81,95%CI,- 13.56至- 6.06,34%),以及胸腔内肝脏(OR 2.70,95%CI,1.60 - 4.57,0%),但在左侧CDH亚组分析中这种关联不再显著。
包括肺测量、胸腔内肝脏和胃位置在内的几种产前影像学表现可预测新生儿存活。肺测量可预测ECMO需求,胸腔内肝脏与持续性PH和ECMO需求显著相关。